Related Experiment Videos

STAT3 mediates the survival signal in oncogenic ras-transfected intestinal epithelial cells

S Zushi1, Y Shinomura, T Kiyohara

  • 1Second Department of Internal Medicine, Osaka University Medical School, Suita, Japan. fwgj9902@mb.infoweb.or.jp

Insights

Oncogenic ras mutations activate signal transducers and activators of transcription 3 (STAT3), promoting cancer cell survival. STAT3 mediates resistance to apoptosis in gastrointestinal cancer cells by upregulating anti-apoptotic proteins.

Area of Science:

  • Gastrointestinal carcinogenesis
  • Cellular signaling pathways
  • Oncology

Background:

  • Oncogenic ras mutations are key in gastrointestinal cancer development.
  • Ras activation triggers an EGF-related peptide autocrine loop, conferring apoptosis resistance.
  • The role of signal transducers and activators of transcription (STATs) in ras-induced cell survival was unclear.

Purpose of the Study:

  • To investigate the role of STATs, specifically STAT3, in the survival signaling of ras-stimulated gastrointestinal cancer cells.
  • To determine if STAT3 activation is essential for the apoptosis resistance observed in these cells.

Main Methods:

  • Constitutive activation of STAT3 in ras-stimulated cells (IEC-ras) was assessed.
  • The effect of an EGF receptor kinase inhibitor (AG 1478) on STAT3 activation was evaluated.
  • Apoptosis resistance was examined in IEC-ras cells with disrupted STAT3 signaling using a dominant-negative STAT3 mutant.
  • The expression of apoptosis-suppressive proteins Bcl-2 and Bcl-xL was analyzed.

Main Results:

  • STAT3 was found to be constitutively activated in ras-stimulated cells.
  • STAT3 activation was significantly inhibited by AG 1478.
  • Disruption of STAT3 signaling abolished apoptosis resistance to UVC and MMC treatments without affecting cell proliferation.
  • Expression of Bcl-2 and Bcl-xL was reduced in cells expressing dominant-negative STAT3.

Conclusions:

  • STAT3 is constitutively activated in ras-stimulated gastrointestinal cancer cells.
  • STAT3 acts as a crucial mediator of the anti-apoptotic signal in these cells.
  • Targeting the STAT3 pathway may offer a therapeutic strategy for gastrointestinal cancers with ras mutations.

Related Concept Videos